T4K3.news

Bankers increasingly rely on hormones to combat aging

Senior bankers turn to testosterone and other substances to maintain their edge in a competitive work environment.

July 18, 2025 at 02:26 PM

"Do you see anyone here older than their 30s?" The unspeakable angst of the ageing banker

Bankers are increasingly using hormones to keep their edge in a cutthroat industry.

Bankers turn to hormones to fight aging

In the high-pressure world of banking, age can feel like a liability. Many senior bankers are resorting to testosterone and other medications to stave off the effects of aging. Alexandra Michel, a former Goldman Sachs associate, now a researcher, found that the pressure to remain competitive leads to desperate measures among seasoned bankers, who feel threatened by younger colleagues. As one director pointed out, those over thirty are often seen as less desirable. Amidst this anxiety, the desire to stay sharp is reshaping attitudes, with both senior and junior bankers using substances to enhance their performance and cope with demands.

Key Takeaways

✔️

Senior bankers are using hormones to maintain competitiveness.

✔️

The culture of youthfulness in banking pressures older employees.

✔️

Junior bankers also turn to stimulant drugs for prolonged alertness.

✔️

High-stress environments foster a reliance on performance enhancements.

✔️

Banking careers are considered unforgiving with little chance of reprieve.

✔️

The financial sector must rethink its values around age and productivity.

"Do you see anyone here older than thirties?"

This quote reflects the age bias in the banking industry.

"I have to work for the unforeseeable future."

A banker expresses the pressure to continue performing at a high level.

"Whatever your body doesn’t have naturally, you can supplement from the outside."

A senior banker speaks on the use of external hormones to maintain performance.

"I chase opportunity. I create income streams, ideally multiple ones at the same time."

A banker shares their approach to staying competitive in the field.

The findings from Michel's research illustrate a troubling trend in the financial sector. As bankers face the relentless pressure to perform and compete, they adopt extreme measures for longevity and performance. This culture could lead to health risks and ethical questions regarding performance-enhancing drugs. The challenge remains: can the industry reshape its values to prioritize wellness alongside ambition?